XML 79 R37.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2019
Income Tax Disclosure [Abstract]  
Schedule of Reconciliation of U.S Federal Statutory Income Tax Rate to Company's Effective Income Tax Rate

A reconciliation of the U.S. federal statutory income tax rate to the Company’s effective income tax rate is as follows:

 

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Federal statutory income tax rate

 

 

(21.0

)%

 

 

(21.0

)%

 

 

(34.0

)%

Research and development tax credits

 

 

(5.8

)

 

 

(7.2

)

 

 

(7.7

)

State taxes, net of federal benefit

 

 

(6.8

)

 

 

(7.2

)

 

 

(4.8

)

Stock-based compensation

 

 

(1.7

)

 

 

2.0

 

 

 

1.2

 

Revaluation of preferred stock warrant liability

 

 

 

 

 

 

 

 

33.1

 

Other

 

 

(0.7

)

 

 

0.8

 

 

 

(0.3

)

Change in deferred tax asset valuation allowance

 

 

36.0

 

 

 

32.6

 

 

 

12.5

 

Effective income tax rate

 

 

%

 

 

%

 

 

%

Schedule of Net Deferred Tax Assets

 

Net deferred tax assets as of December 31, 2019 and 2018 consisted of the following:

 

 

 

December 31,

 

 

 

2019

 

 

2018

 

Deferred tax assets:

 

 

 

 

 

 

 

 

Net operating loss carryforwards

 

$

72,752

 

 

$

50,723

 

Research and development tax credit carryforwards

 

 

36,602

 

 

 

32,522

 

Capitalized organization costs

 

 

244

 

 

 

275

 

Stock-based compensation expense

 

 

12,783

 

 

 

9,178

 

Lease Liability

 

 

5,500

 

 

 

 

Charitable Contributions

 

 

13

 

 

 

11

 

Deferred Revenue

 

 

32,713

 

 

 

37,499

 

Accrued expenses

 

 

1,251

 

 

 

4,279

 

Capitalized research and development expenses

 

 

58

 

 

 

66

 

Total deferred tax assets

 

$

161,916

 

 

$

134,553

 

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

(1,467

)

 

 

(2,544

)

Right of use assets

 

 

(3,103

)

 

 

 

Total deferred tax liabilities

 

 

(4,570

)

 

 

(2,544

)

Valuation allowance

 

$

(157,346

)

 

$

(132,009

)

Net deferred tax assets

 

$

 

 

$

 

Summary of Changes In Valuation Allowance for Deferred Tax Assets

Changes in the valuation allowance for deferred tax assets during the years ended December 31, 2019, 2018 and 2017 related primarily to the increases in NOLs, research and development tax credit carryforwards, stock-based compensation and decrease of the deferred rate due to tax reform were as follows:

 

 

 

Year Ended December 31,

 

 

 

2019

 

 

2018

 

 

2017

 

Valuation allowance at beginning of year

 

$

(132,009

)

 

$

(94,126

)

 

$

(82,994

)

Decreases recorded as benefit to income tax provision

 

 

 

 

 

 

 

 

29,546

 

Increases recorded to income tax provision

 

 

(25,337

)

 

 

(37,883

)

 

 

(40,678

)

Valuation allowance as of end of year

 

$

(157,346

)

 

$

(132,009

)

 

$

(94,126

)